Study guide

12.3 Adrenal & Pituitary Axis Pathology

USMLE Step 2 CK Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Human Development & Well-Patient Care

1.1 Infant, Child & Adolescent Development & Growth 1.2 Adult Development, Aging & Geriatric Assessment 1.3 Preventive Health, Immunization & Well-Patient Screening

2 Chapter 2: Immune System & Immunologic Disorders

2.1 Primary & Secondary Immunodeficiencies 2.2 Hypersensitivity Reactions, Allergy & Anaphylaxis 2.3 Autoimmune & Rheumatologic Disease Principles

3 Chapter 3: Blood & Lymphoreticular System

3.1 Anemias: Microcytic, Normocytic & Macrocytic Etiologies 3.2 Bleeding Disorders, Coagulopathies & Platelet Pathology 3.3 Hematologic Malignancies & Lymphoproliferative Disorders

4 Chapter 4: Behavioral Health & Psychiatric Disorders

4.1 Mood Disorders: Major Depression & Bipolar Spectrum 4.2 Anxiety, Trauma-Related & Somatic Symptom Disorders 4.3 Psychotic Disorders & Schizophrenia Spectrum 4.4 Substance Use Disorders & Psychopharmacology

5 Chapter 5: Nervous System & Special Senses

5.1 Cerebrovascular Disease, Stroke & Transients 5.2 Seizures, Epilepsy & Altered Mental Status 5.3 Movement Disorders, Dementia & Peripheral Neuropathies 5.4 Special Senses: Ophthalmologic & Otolaryngologic Emergencies

6 Chapter 6: Musculoskeletal System & Dermatology

6.1 Fractures, Dislocations & Orthopedic Trauma 6.2 Inflammatory Arthropathies & Crystal-Induced Diseases 6.3 Inflammatory & Infectious Dermatoses 6.4 Cutaneous Malignancies & Blistering Disorders

7 Chapter 7: Cardiovascular System

7.1 Coronary Artery Disease & Acute Coronary Syndromes 7.2 Heart Failure, Cardiomyopathies & Valvular Disease 7.3 Cardiac Arrhythmias, Conduction Blocks & EKG Interpretation 7.4 Vascular Emergencies: Aortic Aneurysms & Peripheral Arterial Disease

8 Chapter 8: Respiratory System

8.1 Obstructive Airway Diseases: Asthma & COPD 8.2 Infectious Pneumonias & Pleural Effusions 8.3 Pulmonary Vascular Disease & Thromboembolism 8.4 Acute Respiratory Distress Syndrome & Interstitial Lung Diseases

9 Chapter 9: Gastrointestinal System

9.1 Esophageal, Gastric & Peptic Ulcer Disorders 9.2 Inflammatory Bowel Disease & Colorectal Neoplasms 9.3 Hepatic Disorders, Cirrhosis & Portal Hypertension 9.4 Biliary Tract Diseases & Pancreatitis

10 Chapter 10: Renal, Urinary & Reproductive Systems

10.1 Acute Kidney Injury & Chronic Kidney Disease 10.2 Glomerular & Tubulointerstitial Diseases 10.3 Nephrolithiasis, Urinary Tract Infections & Prostate Pathology 10.4 Fluid, Electrolyte & Acid-Base Disorders 10.5 Female Reproductive Disorders & Gynecology 10.6 Breast Pathology & Clinical Breast Disease

11 Chapter 11: Pregnancy, Childbirth & Puerperium

11.1 Normal Prenatal Care & Maternal-Fetal Physiology 11.2 Medical & Obstetric Complications of Pregnancy 11.3 Labor, Delivery & Postpartum Management

12 Chapter 12: Endocrine System

12.1 Diabetes Mellitus, Hypoglycemia & Metabolic Emergencies 12.2 Thyroid & Parathyroid Disorders 12.3 Adrenal & Pituitary Axis Pathology

13 Chapter 13: Multisystem Processes & Critical Care

13.1 Shock States, Sepsis & Systemic Inflammatory Response 13.2 Environmental Emergencies, Toxicology & Overdose 13.3 Infectious Disease Principles & Systemic Pathogens

14 Chapter 14: Biostatistics, Epidemiology & Literature Interpretation

14.1 Study Designs, Bias & Validity 14.2 Diagnostic Testing: Sensitivity, Specificity, PPV & NPV 14.3 Statistical Significance, Risk Measures & Evidence-Based Medicine

15 Chapter 15: Social Sciences, Ethics & Systems-Based Practice

15.1 Medical Ethics, Informed Consent & Patient Autonomy 15.2 Legal Issues, Confidentiality & Surrogate Decision Making 15.3 Patient Safety, Quality Improvement & Medical Error Analysis 15.4 Health Care Delivery Systems, Interprofessional Care & Transitions

12.3 Adrenal & Pituitary Axis Pathology

Key Takeaways Explain This Topic AI

Screening for Cushing syndrome utilizes 24-hour urinary free cortisol, late-night salivary cortisol, or 1-mg overnight dexamethasone suppression testing.

Primary adrenal insufficiency presents with hyperkalemia, hyponatremia, hyperpigmentation, and elevated ACTH, whereas secondary adrenal insufficiency retains aldosterone secretion.

Pheochromocytoma management mandates competitive alpha-adrenergic blockade (phenoxybenzamine) for 7-14 days prior to beta-blocker initiation and surgical resection.

Dopamine agonists (cabergoline) are the first-line treatment for prolactinomas of any size, with surgery reserved for medication-resistant cases.

Central Diabetes Insipidus demonstrates a >50% increase in urine osmolality following desmopressin administration, whereas Nephrogenic Diabetes Insipidus exhibits minimal response (<9%).

Last updated: July 2026

  • Adrenal & Pituitary Axis Pathology
  • Adrenal Cortex Pathology: Hypercortisolism & Cushing Syndrome

Hypercortisolism (Cushing syndrome) results from prolonged exposure to excess glucocorticoids. Etiologies are divided into ACTH-dependent (Cushing disease [pituitary ACTH adenoma], Ectopic ACTH [small cell lung carcinoma]) and ACTH-independent (exogenous steroids, adrenal adenoma/carcinoma, bilateral adrenal hyperplasia).

Diagnostic Workup of Suspected Cushing Syndrome

Screening requires establishing hypercortisolism using at least one of three validated first-line tests: (1) 24-hour Urinary Free Cortisol , (2) Late-Night Salivary Cortisol , or (3) 1-mg Overnight Dexamethasone Suppression Test (DST) (failure to suppress morning cortisol to <1.8 µg/dL). [ Clinical Features of Hypercortisolism ]

  • (Central obesity, striae, hypertension)
  • │
  • [ Perform Initial Screen ]
  • (24-hr UFC, Late-Night Salivary, 1-mg DST)
  • │
  • [ Cortisol Elevated ]
  • │
  • [ Measure Plasma ACTH ]
  • │
  • ┌──────────────────────────────┴──────────────────────────────┐
  • [ Low ACTH (<5 pg/mL) ] [ High ACTH (>20 pg/mL) ]
  • (ACTH-Independent) (ACTH-Dependent)
  • │ │
  • [ Abdominal CT/MRI ] [ High-Dose (8-mg) DST ]
  • │ │
  • ┌─────────────┴─────────────┐ ┌──────────────┴──────────────┐
  • ▼ ▼ ▼ ▼
  • Adrenal Adenoma / Exogenous Steroids [ Cortisol Suppressed ] [ No Suppression ]
  • Carcinoma (Clinical History) (Cushing Disease) (Ectopic ACTH)
  • │ │
  • ▼ ▼
  • Pituitary MRI Chest CT Scan
  • Adrenal Insufficiency & Primary Hyperaldosteronism

Adrenal insufficiency (AI) represents deficient adrenocortical hormone production. Primary AI (Addison Disease) is caused by intrinsic destruction of the adrenal cortex (autoimmune adrenalitis in developed nations; tuberculosis worldwide), causing deficiency of glucocorticoids, mineralocorticoids, and adrenal androgens. Secondary AI is caused by pituitary hypofunction or abrupt cessation of long-term glucocorticoids, resulting in deficient ACTH and cortisol while mineralocorticoid production remains intact (regulated by RAAS).

  • Clinical/Laboratory Feature Primary Adrenal Insufficiency (Addison) Secondary Adrenal Insufficiency
  • Plasma Cortisol & ACTH Low Cortisol, Markedly High ACTH Low Cortisol, Low/Normal ACTH
  • Aldosterone Secretion Deficient (Renin is High) Intact (Renin is Normal)
  • Serum Electrolytes Hyponatremia, Hyperkalemia , Acidosis Hyponatremia (Euvolemic), Normal Potassium
  • Skin Hyperpigmentation Present (POMC cleavage yields MSH) Absent
  • ACTH Stimulation Test Peak Cortisol <18 µg/dL (No response) Subnormal or Delayed Response
  • Treatment Hydrocortisone + Fludrocortisone Hydrocortisone alone
  • Adrenal Crisis Management

Adrenal crisis is a life-threatening medical emergency presenting with profound shock refractory to vasopressors, fever, confusion, and severe abdominal pain. Treatment must be initiated immediately upon clinical suspicion :

High-dose IV Hydrocortisone 100 mg bolus , followed by 200 mg/24 hours continuous infusion or 50 mg IV every 6 hours.

Rapid infusion of 0.9% Normal Saline with 5% Dextrose to restore intravascular volume and correct hypoglycemia.

Diagnostic testing (cosyntropin stimulation test) should never delay treatment . If testing must be performed during crisis, use Dexamethasone as it does not cross-react with serum cortisol assays.

Primary Hyperaldosteronism (Conn Syndrome)

Autonomous aldosterone hypersecretion by an adrenal adenoma (Conn syndrome, 30%) or bilateral adrenal hyperplasia (70%). Features include resistant hypertension, hypokalemia (often normokalemic early), muscle weakness, and metabolic alkalosis.

Screening : Morning Plasma Aldosterone Concentration (PAC) to Plasma Renin Activity (PRA) ratio >20 with PAC >15 ng/dL.

Confirmation : Oral salt loading test or IV saline infusion test (failure to suppress PAC <5 ng/dL).

Subtype Localization : Abdominal CT followed by Bilateral Adrenal Venous Sampling (AVS) to distinguish unilateral adenoma (cured by laparoscopic adrenalectomy) from bilateral hyperplasia (treated medically with Spironolactone or Eplerenone ).

Pheochromocytoma: Preoperative Medical Management

Pheochromocytoma is a catecholamine-secreting tumor of chromaffin cells in the adrenal medulla (or extra-adrenal paraganglioma). It presents with the classic triad of episodic headache, sweating (diaphoresis), and tachycardia , associated with paroxysmal or persistent hypertension.

Diagnosis : Elevated plasma free metanephrines or 24-hour urinary fractionated metanephrines and catecholamines, followed by abdominal CT or MRI.

Preoperative Medical Management Protocol :

Alpha-Adrenergic Blockade FIRST : Administer non-selective, irreversible alpha-blocker Phenoxybenzamine (or selective alpha-1 blocker doxazosin) for 7 to 14 days prior to surgery to expand intravascular volume and control blood pressure.

Beta-Adrenergic Blockade SECOND : Initiate Propranolol or atenolol only 2 to 3 days prior to surgery to control tachyarrhythmias.

CRITICAL WARNING : Never start beta-blockers before alpha-blockers . Blockade of vasodilatory beta-2 receptors in the presence of unopposed alpha-1 stimulation triggers catastrophic, fatal hypertensive crises and acute pulmonary edema.

  • Hypothalamic & Pituitary Pathology
  • Hyperprolactinemia & Prolactinoma

Prolactin is inhibited tonically by hypothalamic dopamine. Hyperprolactinemia presents with hypogonadism, galactorrhea, amenorrhea, decreased libido, and erectile dysfunction. Macroadenomas (>10 mm) cause mass effect (bitemporal hemianopsia, headache).

Workup : Exclude pregnancy, primary hypothyroidism (elevated TRH stimulates prolactin), and dopamine-blocking medications (antipsychotics, metoclopramide). Order pituitary MRI.

Treatment : Dopamine Agonists (Cabergoline preferred over Bromocriptine) are first-line for all prolactinomas (micro- and macroadenomas) to shrink tumor size and restore gonadal function. Transsphenoidal surgery is reserved for tumors resistant or intolerant to dopamine agonists.

Acromegaly

Growth Hormone (GH) hypersecretion by a pituitary somatotroph adenoma. Features include acral tissue overgrowth (increased shoe/glove size), coarse facial features, macroglossia, hypertension, cardiomyopathy, diabetes mellitus, and colonic polyps.

Screening : Elevated serum Insulin-like Growth Factor 1 (IGF-1) .

Confirmation : Oral Glucose Tolerance Test (OGTT) demonstrating failure of serum GH suppression to <1 ng/mL after 75g oral glucose load.

Treatment : First-line is Transsphenoidal Surgical Resection . Medical therapy includes Somatostatin Analogs (Octreotide, Lanreotide) or GH receptor antagonists (Pegvisomant).

Diabetes Insipidus (DI) vs. SIADH

Diagnostic Parameter Central Diabetes Insipidus Nephrogenic Diabetes Insipidus SIADH

Pathophysiology Lack of ADH secretion from posterior pituitary Renal V2 receptor resistance to ADH (Lithium, Hypercalcemia) Unregulated excess ADH secretion (Small cell lung cancer, CNS disease)

Serum Sodium / Osmolality High/Normal (>145 mEq/L) / Hyperosmolar High/Normal (>145 mEq/L) / Hyperosmolar Hyponatremia (<135 mEq/L) / Hypoosmolar (<275 mOsm/kg)

Urine Osmolality Dilute (<300 mOsm/kg) Dilute (<300 mOsm/kg) Concentrated (>100 mOsm/kg)

Water Deprivation Test Urine Osmolality increases >50% after Desmopressin (dDAVP) Urine Osmolality increases <9% after Desmopressin N/A (Euvolemic hyponatremia)

First-Line Treatment Desmopressin (dDAVP) Discontinue offending drug, Thiazides, Amiloride Fluid Restriction (800–1000 mL/day) , Oral Salt; 3% Hypertonic Saline if severe.